Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;24(1):67-71.
doi: 10.1007/s11670-012-0067-1.

Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and cathepsin L in diagnosis of ovarian cancer

Affiliations

Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and cathepsin L in diagnosis of ovarian cancer

Wei Zhang et al. Chin J Cancer Res. 2012 Mar.

Abstract

Objective: To investigate the clinic values of combining test of serum matrix metalloproteinase 9 (MMP-9), acetyl heparinase (Hpa) and Cathepsin L (CL) in diagnosis of ovarian cancer.

Methods: Serum levels of MMP-9, Hpa and CL were detected in a total of 418 cases, including 217 cases with ovarian malignant tumor, 100 cases with ovarian benign tumor and 101 healthy controls, by using enzyme-linked immunosorbent assay (ELISA). Their correlation with clinicopathologic feature of ovarian malignant tumor was analyzed and their diagnosis performance was evaluated by receiver operating characteristic (ROC). The combined diagnosis model was established by logistic regression analysis.

Results: The serum levels of MMP-9, Hpa and CL were significantly higher in patients with ovarian malignant tumor than in benign tumor and healthy control, the serum levels of CL and Hpa were higher in epithelial cancer than in non-epithelial tumor, and MMP-9, Hpa and CL were elevated in low grade and advanced stage compared to high grade and early stage. The sensitivity for diagnosis of ovarian malignant tumor from high to low was CL, Hpa and MMP-9, and the specificity was MMP-9, CL and Hpa. The united diagnosis model was established and showed the sensitivity and specificity of combined detection were 84.6% and 82.1%, respectively, which were significantly higher than a single tumor marker.

Conclusion: Serum MMP-9, Hpa and CL were correlated with ovarian malignant tumor and the combined detection of which may be valuable for clinical diagnosis of ovarian malignant tumor.

Keywords: Acetyl heparinase; Cathepsin; Diagnosis; Matrix metalloproteinase 9; Ovarian cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ROC curve of CL, Hpa, MMP-9 and CA125.

Similar articles

Cited by

References

    1. Shaaban A, Rezvani M.Ovarian cancer: detection and radiologic staging. Clin Obstet Gynecol 2009;52:73-93 - PubMed
    1. Chen WQ, Zhang SW, Zou XN, et al. Cancer incidence and mortality in China, 2006. Chin J Cancer Res 2011;23:3-9 - PMC - PubMed
    1. Nolen B, Velikokhatnaya L, Marrangoni A, et al. Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol 2010;117:440-5 - PMC - PubMed
    1. Wang SM, Li L, Zhang W, et al. Clinical value of detection of serum cathepsin L on diagnosis of ovarian cancer. Zhong Guo Zhong Liu Lin Chuang (in Chinese)2008;35:167-8
    1. Zhou J, Li L, Wang SM, et al. Elevated Serum Level of MMP-9 in malignant ovarian tumor and its clinical significance. Shi Yong Fu Chan Ke Za Zhi (in Chinese)2008;24:346-9